Heads is a full-service global Contract Research Organization (CRO) dedicated to the conduct of clinical studies, with particular expertise in hemato-oncology. We provide the complete range of clinical research services, from start-up to publication, from Phase 1 to 4. In addition, we provide strategic oncology drug development consulting and expert advice as we understand the challenges of developing anti-cancer drugs in the complex, highly competitive and rapidly developing oncology market. With offices in North America, Europe, Asia-Pacific, Heads has been established as one of the leading CROs in hemato-oncology delivering key Phase 1/2 and Pivotal Phase 3 studies. Heads has invested considerably in its infrastructure. We strive to employ top professionals and develop premier software to meet and exceed our client needs. At Heads we believe in true passion and devotion; every day we bring these in our work. That's the secret behind our success.